Stockholm, December 15, 2021 - Nasdaq Stockholm has decided to temporarily stop trading in Intervacc after a volatile trading session and a decline in the share price. The reason for the price decline is speculation in ... Read more
Stockholm, December 14, 2021 - Intervacc AB (“Intervacc”) announces today that sales of the company’s Strangles vaccine Strangvac are planned to begin in the first quarter of 2022.
Intervacc's ... Read more
Stockholm, November 30, 2021 - According to the principles for the appointment of the Nomination Committee in Intervacc AB (publ) adopted at the annual general meeting held on June 9th, 2021, the Nomination Committee ... Read more
The period in summary
Third quarter July 1 – September 30, 2021
- On August 16th the European Commission ... Read more
Stockholm, November 8, 2021 - Intervacc AB (“Intervacc”) announces that the United States Patent and Trademark Office has granted an approval for Intervacc's patent application in the United States for a vaccine against ... Read more
